Keywords
Colombia
Laboratory
Physicians
Thrombophilia
How to Cite
Abstract
Introduction: thrombophilia are a group of blood disorders, acquired or hereditary, characterized by a predisposition to the formation of venous or arterial thrombi. In clinical practice, variability exists in the criteria for the selection of patients to study or the laboratory work up for thrombophilia in arterial thrombosis. Objective: describe and determine the variability in Colombian medical specialists in the criteria for the evaluation of thrombophilias in adult patients with arterial thrombosis. Methods: between September 2021 and January 2022, through an on-line survey to medical specialists in Colombia, caring for patients with arterial thrombosis, criteria for patient selection and laboratory work up for the study of thrombophilia in arterial thrombosis were surveyed. The physicians surveyed were selected by convenience and were contacted in person or via email. Results: in 102 surveys, 48 % neurologists, 44 patterns for patient selection criteria for the study of thrombophilias in arterial thrombosis were observed (42,57 % variability index). The two more common patterns included family history, recurrent arterial thrombosis, age 50 %) for the study of thrombophilia in arterial thrombosis patients were anticardiolipin antibodies (95,1 %), lupus anticoagulant (95,1 %). Conclusion: among Colombian medical specialists caring for adult patients with arterial thrombosis there is variability for the selection criteria and laboratory work up for the study of thrombophilias.
References
Linnemann B, Hart C. Laboratory Diagnostics in Thrombophilia. Hamostaseologie. 2019;39(1):49- 61.
Moll S. Thrombophilia: clinical-practical aspects. J Thromb Thrombolysis. 2015;39(3):367-378.
Padda J, Khalid K, Mohan A, Pokhriyal S, Batra N, Hitawala G, et al. Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome. Cureus. 2021;13(8):e17185.
Dautaj A, Krasi G, Bushati V, Precone V, Gheza M, Fioretti F, et al. Hereditary thrombophilia. Acta Biomed. 2019;90(10-S):44-46.
Lalouschek W, Schillinger M, Hsieh K, Endler G, Tentschert S, Lang W, et al. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke. 2005;36(7):1405-1409.
Holzhauer S, Goldenberg NA, Junker R, Heller C, Stoll M, Manner D, et al. Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study. Blood. 2012;120(7):1510- 1515.
Khan S, Dickerman JD. Hereditary thrombophilia. Thromb J. 2006;4:15.
de Moerloose P, Boehlen F. Inherited thrombophilia in arterial disease: a selective review. Semin Hematol. 2007;44(2):106-113.
Baena JC, Murcia AM, Franco MA, Moreno I, Donaldo J, Castro A, et al. Factor V Leiden y otras trombofilias, frecuencia en un centro de alta complejidad de Cali (Colombia). Rev Col Hematol Oncol. 5(1):42-49.
Torres JD, Cardona H, Alvarez L, Cardona-Maya W, Castañeda SA, Quintero-Rivera F, et al. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population. Am J Hematol. 2006;81(12):933-937.
Rambaldi MP, Mecacci F, Guaschino S, Paidas MJ. Inherited and acquired thrombophilias. Reprod Sci. 2014;21(2):167-182.
Andreoli L, Chighizola CB, Banzato A, PonsEstel GJ, Ramire de Jesus G, Erkan D. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res (Hoboken). 2013;65(11):1869-1873.
Zhao Y, Huang C, Qi W, Zhou Y, Zhao J, Wang Q, et al. Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort. RMD Open. 2023;9(3):1-11.
Cheng C, Cheng GY, Denas G, Pengo V. Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review. Blood Rev. 2021;48:1-11.
O’Donnell M, Shatzel JJ, Olson SR, Daughety MM, Nguyen KP, Hum J, et al. Arterial thrombosis in unusual sites: A practical review. Eur J Haematol. 2018;101(6):728-736.
Carroll BJ, Piazza G. Hypercoagulable states in arterial and venous thrombosis: When, how, and who to test? Vasc Med. 2018;23(4):388-399.
Schöberl F, Ringleb PA, Wakili R, Poli S, Wollenweber FA, Kellert L. Juvenile Stroke. Dtsch Arztebl Int. 2017;114(31-32):527-534.
Boekholdt SM, Kramer MHH. Arterial thrombosis and the role of thrombophilia. Semin Thromb Hemost. 2007;33(6):588-596.
Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209-220.
Chiasakul T, De Jesus E, Tong J, Chen Y, Crowther M, Garcia D, et al. Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta‐Analysis. J Am Heart Assoc. 2019;8(19):e012877.
Crespo-Pimentel B, Willeit J, Töll T, Kiechl S, PinhoE-Melo T, Canhão P, et al. Etiologic Evaluation of Ischemic Stroke in Young Adults: A Comparative Study between Two European Centers. J Stroke Cerebrovasc Dis. 2019;28(5):1261-1266.
Orozco-Burbano JD, Urbano-Albán DC, ZamoraBastidas TO. Ischemic stroke in a young patient, is it needed to look for a thrombophilia?Rev. med. Risaralda. 2022;28(1):105-113.
Colucci G, Tsakiris DA. Thrombophilia screening revisited: an issue of personalized medicine. J Thromb Thrombolysis. 2020;49(4):618-629.
May JE, Moll S. Unexplained arterial thrombosis: approach to diagnosis and treatment. Hematology Am Soc Hematol Educ Program. 2021;2021(1):76-84.
Shen YM, Tsai J, Taiwo E, Gavva C, Yates SG, Patel V, et al. Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost. PLoS One. 2016;11(5):e0155326.
Arachchillage DJ, Mackillop L, Chandratheva A, Motawani J, MacCallum P, Laffan M. Thrombophilia testing: A British Society for Haematology guideline. Br. J. Haematol. 2022;198(3):443-458.
Zhang Y, Zhou Y, Wang Y, Teng G, Dapeng L, Wang Y, et al. Thrombosis among 1537 patients with JAK2V617F‐mutated myeloproliferative neoplasms: Risk factors and development of a predictive model. Cancer Med. 2020;9(6):2096-2105.
Ashraf N, Visweshwar N, Jaglal M, Sokol L, Laber D. Evolving paradigm in thrombophilia screening. Blood Coagul Fibrinolysis. 2019;30(5):249-252.
Salehi Omran S, Hartman A, Zakai NA, Navi BB. Thrombophilia Testing After Ischemic Stroke. Stroke. 2021;52(5):1874-1884.
Dawn S, Connors J, Thachil J. Dilemmas in hematology: consults in patients with arterial thrombosis. J Thromb Haemost. 2023;21(3):421- 432.
Omran SS, Lerario MP, Gialdini G, Merkler AE, Moya A, Chen ML, et al. Clinical Impact of Thrombophilia Screening in Young Adults with Ischemic Stroke. J Stroke Cerebrovasc Dis. 2019;28(4):882-889.
Gehlenborg N. UpSetR: A More Scalable Alternative to Venn and Euler Diagrams for Visualizing Intersecting Sets. Version 1.4.0 from CRAN [Internet]. 2019. Disponible en: https:// CRAN.R-project.org/package=UpSetR
Ng KWP, Loh PK, Sharma VK. Role of Investigating Thrombophilic Disorders in Young Stroke. Stroke Res Treat. 2011:670138.
Gallo D, del Carmen M, Sanchez Luceros D, Altuna A, Ceresetto D, Fassi J. Trombofilias. En: Sociedad Argentina de Hematología. Hemostasia y Trombosis. Guías de Diagnóstico y Tratamiento; Argentina. 2019. p. 237-245.
Kim K, Cox N, Witt DM. Stroke diagnosis associated with thrombophilia testing overutilization. Thromb Res. 2017;157:139-141.
Guillermo C, Blanco A, Echenagucia M, Garcia D, Steffano B, Merola B, et al. Estudio de trombofilia en Latinoamérica. Revista Hematologia. 2017;21(1):22-30.
Raslan O, Tran C, Al-Ani F, Sposato L, LazoLangner A. Prevalence of Thrombophilia in Transient Ischemic Attack and Ischemic Stroke Patients. Blood. 2020;136(Supplement 1):3.
Alakbarzade V, Taylor A, Scully M, Simister R, Chandratheva A. Utility of current thrombophilia screening in young patients with stroke and TIA. Stroke Vasc Neurol. 2018;3(4):231-236.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke A. Stroke. 2019;50(12):e344-e418.
Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Tagawa ST, et al. Arterial thromboembolic events preceding the diagnosis of cancer in older persons. Blood. 2019;133(8):781-789.
Franchini M, Tufano A, Casoria A, Coppola A. Arterial Thrombosis in Cancer Patients: An Update. Semin Thromb Hemost. 2021;47(8):942-949.
Ettinger DS, Agulnik M, Cates JM, Cristea M, Denlinger CS, Eaton KD, et al. NCCN Clinical Practice Guidelines Occult primary. J Natl Compr Canc Netw. 2011;9(12):1358-1395.
Katz OB, Brenner B, Horowitz NA. Thrombosis in vasculitic disorders-clinical manifestations, pathogenesis and management. Thromb Res. 2015;136(3):504-512.
Springer J, Villa-Forte A. Thrombosis in vasculitis. Curr Opin Rheumatol. 2013;25(1):19-25.
Middeldorp S. Inherited thrombophilia: a doubleedged sword. Hematology Am Soc Hematol Educ Program. 2016;2016(1):1-9.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Médicas UIS